Research Update: Lord & Taylor Holdings LLC Assigned 'B+' Corporate Credit Rating; Proposed Term Loan Assigned 'BB' Rating Jan 12

  • ID: 2044545
  • January 2012
  • Standard & Poors
1 of 3

U.S. specialty-retail department store chain Lord & Taylor is refinancing its existing capital structure. After receiving final documents and reviewing the terms, we are assigning our 'B+' corporate credit rating to the company. We are also assigning our 'BB' issue-level rating with a '1' recovery rating to the company's proposed $450 million term loan. The stable outlook reflects our expectations that the company will demonstrate performance gains over the near term, but at a lower rate given the difficult economy. On Jan. 24, 2012, Standard & Poor's Ratings Services assigned its 'B+' corporate credit rating to New York City-based Lord & Taylor Holdings LLC. The outlook is stable. At the same time, we assigned our 'BB' issue-level rating and '1'...

Companies mentioned in this report are: Lord & Taylor Holdings LLC
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Product Type: Research Update
Research updates complement media releases. They offer more depth and detail than summary analyses by incorporating all information published in the media release. They are more up to date than summaries in that they are published simultaneously with media releases.

Note: Product cover images may vary from those shown
2 of 3

Lord & Taylor Holdings LLC

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.